Results     28-May-24
Announcements
Astrazeneca Pharma India standalone net profit rises 128.60% in the March 2024 quarter
Sales rise 34.60% to Rs 383.20 crore
Net profit of Astrazeneca Pharma India rose 128.60% to Rs 39.48 crore in the quarter ended March 2024 as against Rs 17.27 crore during the previous quarter ended March 2023. Sales rose 34.60% to Rs 383.20 crore in the quarter ended March 2024 as against Rs 284.70 crore during the previous quarter ended March 2023.

For the full year,net profit rose 62.66% to Rs 161.51 crore in the year ended March 2024 as against Rs 99.29 crore during the previous year ended March 2023. Sales rose 29.17% to Rs 1295.53 crore in the year ended March 2024 as against Rs 1002.97 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales383.20284.70 35 1295.531002.97 29
OPM %12.8921.02 -14.2416.46 -
PBDT58.1267.76 -14 218.05190.59 14
PBT54.3663.51 -14 203.11174.33 17
NP39.4817.27 129 161.5199.29 63

Previous News
  Astrazeneca Pharma India fixes record date for final dividend
 ( Market Beat - Reports 27-Jun-22   17:01 )
  Astrazeneca Pharma India declare Quarterly Result
 ( Corporate News - 16-May-24   14:53 )
  Astrazeneca Pharma India to conduct AGM
 ( Corporate News - 16-Jul-22   17:26 )
  Astrazeneca Pharma India standalone net profit rises 128.60% in the March 2024 quarter
 ( Results - Announcements 28-May-24   07:37 )
  Astrazeneca Pharma India to table results
 ( Corporate News - 31-Oct-23   14:03 )
  Volumes spurt at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 27-May-22   11:00 )
  AstraZeneca receives import and market permission for Acalabrutinib 100mg capsules
 ( Corporate News - 13-Mar-20   10:07 )
  AstraZeneca Pharma India fixes record date for dividend
 ( Market Beat - Reports 03-Jul-23   18:19 )
  Astrazeneca Pharma India standalone net profit declines 45.03% in the June 2021 quarter
 ( Results - Announcements 09-Aug-21   15:05 )
  AstraZeneca Pharma receives DCGI approves to import pharmaceutical formulation for Dapagliflozin Tablets
 ( Corporate News - 24-Jul-23   18:05 )
  Volumes soar at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 07-Feb-19   11:00 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top